HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jörg Bittenbring Selected Research
Jörg Bittenbring Research Topics
Disease
5
Neoplasms (Cancer)
01/2023 - 01/2017
3
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2022 - 01/2018
2
Graft vs Host Disease (Graft-Versus-Host Disease)
12/2023 - 01/2017
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 02/2017
1
Virus Diseases (Viral Diseases)
01/2018
1
Leukemia
02/2017
1
Pathologic Complete Response
02/2017
1
Hematologic Neoplasms (Hematological Malignancy)
01/2017
1
B-Cell Lymphoma (Lymphoma, B Cell)
04/2014
Drug/Important Bio-Agent (IBA)
2
idelalisib
IBA
02/2022 - 01/2021
1
treosulfan
IBA
01/2019
1
fludarabine
IBA
01/2019
1
18S Ribosomal RNA
IBA
01/2017
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
04/2014
1
Rituximab (Mabthera)
FDA Link
04/2014
1
Prednisone (Sone)
FDA Link
Generic
04/2014
1
Vincristine (Oncovin)
FDA Link
Generic
04/2014
1
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2014
Therapy/Procedure
5
Stem Cell Transplantation
02/2022 - 01/2017
4
Hematopoietic Stem Cell Transplantation
12/2023 - 01/2017
4
Transplantation
01/2019 - 01/2017
2
Cell Transplantation
01/2023 - 01/2021
1
Radiotherapy
04/2014